Does the substance being studied actually help restore function? We distinguish laboratory findings from observations in patients.
Separate pathways in this area: BPC-157 · TB-500 · GHK-Cu.
A research question connects these topics. The quality of evidence and each substance's status may differ completely.
Learn the terms, how to read research and the key safety information.
Recovery / Sport
BPC-157 is studied mainly for tissue healing. It often appears in discussions of injuries, joint pain and recovery, but most evidence comes from laboratories and animal experiments. The few human-use reports are too small to establish a proven treatment.
Recovery / Sport
TB-500 is a name under which different substances are easily confused. In the FDA assessment it means a short thymosin beta-4 fragment, not the whole molecule. Studies of full-length thymosin, including eye products, do not automatically establish TB-500's effects on human sports injuries, tendons or muscles.
Health / Recovery
GHK-Cu combines a short peptide with copper. It is most often discussed in relation to skin, collagen and cosmetics. Laboratory studies and small studies of products applied to the skin exist. However, they do not justify regarding GHK-Cu injections as an established way to rejuvenate the whole body.
News about a regulatory change or a small study may sound like a breakthrough. For BPC-157, it is worth checking exactly what it concerns.
Saying that thymosin beta-4 has been studied does not yet answer the question about TB-500. The exact molecule, route of administration and participants' health condition all matter.
Small studies of a skin cream and an eyebrow serum appeared in 2026. They are worth knowing about, but should not be treated as evidence of broad anti-ageing effects.